|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-7-7
|
|
pubmed:abstractText |
The expression of HER2/neu has been identified as a prognostic factor in several malignant diseases. However, only sparse data exist correlating HER2/neu expression in soft tissue sarcoma with subsequent tumor progression or recurrence. The purpose of this study was to investigate the clinical significance of HER2/neu in adult soft tissue sarcoma (STS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0378-584X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 S. Karger GmbH, Freiburg
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
268-71
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:12845212-Adult,
pubmed-meshheading:12845212-Aged,
pubmed-meshheading:12845212-Biopsy,
pubmed-meshheading:12845212-Female,
pubmed-meshheading:12845212-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:12845212-Humans,
pubmed-meshheading:12845212-Immunoenzyme Techniques,
pubmed-meshheading:12845212-Male,
pubmed-meshheading:12845212-Middle Aged,
pubmed-meshheading:12845212-Neoplasm Recurrence, Local,
pubmed-meshheading:12845212-Neoplasm Staging,
pubmed-meshheading:12845212-Prognosis,
pubmed-meshheading:12845212-Receptor, erbB-2,
pubmed-meshheading:12845212-Sarcoma,
pubmed-meshheading:12845212-Soft Tissue Neoplasms,
pubmed-meshheading:12845212-Survival Rate,
pubmed-meshheading:12845212-Tumor Markers, Biological
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Expression of HER2/neu does not correlate with survival in soft tissue sarcoma.
|
|
pubmed:affiliation |
Klinik für Chirurgie, Universitätsklinikum Eppendorf, Hamburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
